staar surgical stock news
STAA shares down more than 50 in the past six months stockholders are in sore need of some good news. Data is currently not available.
Down Over 50 In 6 Months Is Staar Surgical Still A Buy Nasdaq
Staar Surgical STAA delivered earnings and revenue surprises of 1875 and 050 respectively for the quarter ended December 2021.
. STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results. 6 analysts expect earnings of 0170 per share as opposed to earnings of 0140 per share in the same quarter of the previous. Make Positive Change With Our Powerfull News Alerts Price Tracking Portfolio Monitoring.
STAAR Surgical Company Common Stock STAA Nasdaq Listed. STAA Complete Staar Surgical Co. STAAR Surgical Company will be releasing earnings Q4on February 23.
Igor KutyaeviStock via Getty Images STAAR Surgical STAA 117 stock rose following its earnings results where Q4 net sales grew 28 YY to 59M. STAA Q2 sales increased 77 YY to 624 million and up 23 on a sequential basis beating the consensus of 5256 million. STAAR Surgical NasdaqGMSTAA Stock Report Last Price US6623 Market Cap US32b 7D -128 1Y -463 Updated 19 Feb 2022 Data Company Financials 6 Analysts Overview 1 Valuation 2 Future 3 Past 4 Health 5 Dividend 6 Management 7 Ownership Information STAA Stock Overview.
Real time STAAR Surgical STAA stock price quote stock graph news analysis. View real-time stock prices and stock quotes for a full financial overview. Get the latest stock news for Nasdaq companies press releases financial disclosures and multimedia content for day traders investment community individual investors and the general public.
Street Est of 0. Uplifts FY21 Outlook STAAR Surgical Company NASDAQ. Staar Surgical Co.
- STAA stock news. STAAR Surgical Stock Surges 21 After Q2 Sales Beat Expectations. Ad Stock Prices Changes of 10 or More Result From a Single News Headline.
STAA a leading developer manufacturer and marketer of implantable lenses and companion delivery systems for the eye today reported financial results for the fourth quarter. A high-level overview of STAAR Surgical Company STAA stock. The company said the increase was driven by.
STAAR Surgical to Report Fourth. 6 months ago - Benzinga. On average they expect STAAR Surgicals share price to reach 15000 in the next year.
Dont Be Left Out. Stock news by MarketWatch. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.
STAAR Surgical News Headlines 6623 -261 -379 As of 02182022 1200 AM ET Todays Range 6581 6930 50-Day Range 6539 9626 52-Week Range 6325 16308 Volume 335380 shs Average Volume 372285 shs Market Capitalization 315 billion PE Ratio 14398 Dividend Yield NA Beta 092 Profile Analyst Ratings Chart Competitors. STAAR Surgical shareholders can take confidence from the fact that EBIT margins are up from 39 to 14 and revenue is growing. Do the numbers hold clues to what lies ahead for the stock.
The stock current value is 7456Recently in News on February 23 2022 STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results. STAAR Surgical Company NASDAQ. This suggests a possible upside of.
No significant news for in the past two years. Ticking those two boxes is a good sign of growth in my book. With STAAR Surgical NASDAQ.
BNK Invest Oct 13 2021 With STAAR Surgical Companys NASDAQSTAA price down 60 this week insiders might find some solace having sold US97m worth of. 2 days agoRTTNews Feb. News Staar Surgical Co.
Earnings Flash STAA STAAR SURGICAL COMPANY Reports Q4 EPS 019 vs. Get STAAR Surgical Co STAANASDAQ real-time stock quotes news price and financial information from CNBC. 263 275 DATA AS OF Dec 08 2021.
23 2022 0432 PM RTTNews - STAAR Surgical Company STAA announced a profit for its fourth quarter that increased from last year and beat the Street estimates. Key Stock Data PE Ratio TTM 16367 021122 EPS TTM 046 Market Cap. 3 analysts have issued 12-month price objectives for STAAR Surgicals shares.
Their forecasts range from 15000 to 15000. The growth was attributable to global ICL sal.
Staar Surgical Company Staar Surgical Introduces Evo Viva Presbyopia Correcting Lens See Young Again
Rsi Alert Staar Surgical Staa Now Oversold Nasdaq
Is It Too Late To Buy Staar Surgical Stock The Motley Fool
Staar Surgical Stock Drastically Overpriced Nasdaq Staa Seeking Alpha
Staar Surgical Stock Bright Future But Hit The Pause Button Nasdaq Staa Seeking Alpha
Down Over 50 In 6 Months Is Staar Surgical Still A Buy Nasdaq
Down More Than 18 In 3 Months Is Staar Surgical Still A Buy The Motley Fool
Staar Surgical Staa May Find A Bottom Soon Here S Why You Should Buy The Stock Now Nasdaq
Staar Surgical Announces Closing Of Common Stock Offering Staar Surgical
Staar Surgical Staa May Find A Bottom Soon Here S Why You Should Buy The Stock Now
Staa Stock Price And Chart Nasdaq Staa Tradingview
Should You Be Adding Staar Surgical Nasdaq Staa To Your Watchlist Today Simply Wall St News
Staar Surgical Evo Visian Icl Certification Course 8th October 2017 Lisbon Http Albertobellone It Al Dry Eye Syndrome Patient Education Healthy Eyes
Staar Surgical Announces Pricing Of Public Offering Of Common Stock Business Wire
Staar Surgical Stock Drastically Overpriced Nasdaq Staa Seeking Alpha